Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (29 ops.)
Latest filing published 02 Oct 2026 for NEOGEN CORP, €106k.
Filing timeline
BuySaleAndrea F. Wainer
Insider track record
Disclosed buys
0
Disclosed sells
29
Signal history
Andrea F. Wainer: trading record in brief
Andrea F. Wainer, EXECUTIVE VICE PRESIDENT of Abbott Laboratories (65 filings), also serves as a Director at Neogen Corp (3) and Analog Devices Inc (2). The record has 70 filings between June 5, 2019 and October 2, 2026. The 29 sales, all at Abbott Laboratories for the three largest, total EUR 22.5 million, with a median of EUR 489,794: EUR 2,737,795 on September 30, 2020, then EUR 2,593,715 and EUR 1,815,601 on January 29, 2024. No purchase is in the record, which holds 21 grants and 20 option exercises.
The year 2021 is the fullest with 26 filings, ahead of 2023 (14). Three filings fall in the last 12 months, with no sale. Filings are published a median of 2 days after the trade, across 70 dated filings.
At Abbott Laboratories, 15 of Wainer's trades are within 30 days of a trade by Daniel Gesua Sive Salvadori, 10 of one by Randel William Woodgrift and 9 of one by Louis H. Morrone, all in the same direction.
Companies and markets linked to Andrea F. Wainer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations70 total
9,804 shares@ US$12.2444.2% of flowRestricted Stock UnitsSEC:0000711377-26-000027:0
747 shares0Comm Stock - $.16-2/3 valueSEC:0001778070-26-000002:0
19,769 shares@ US$6.0777.3% of flowCommon StockSEC:0000711377-25-000055:0
6,090 shares@ US$5.6922.7% of flowCommon StockSEC:0000711377-25-000022:0
1,160 shares0Comm Stock - $.16-2/3 valueSEC:0000006281-25-000058:0
7,313 shares@ US$135.8710.1% of flowCommon shares without par valueSEC:0001415889-25-006798:0
949 shares@ US$138.171.3% of flowCommon shares without par valueSEC:0001415889-25-006798:1
12,278 shares0Common shares without par valueSEC:0001415889-25-005920:0
8,339 shares@ US$120.059.8% of flowCommon shares without par valueSEC:0001415889-24-006422:0
12,500 shares@ US$59.947.3% of flowCommon shares without par valueSEC:0001415889-24-005576:0
12,500 shares@ US$120.0014.7% of flowCommon shares without par valueSEC:0001415889-24-005576:1
13,677 shares0Common shares without par valueSEC:0001415889-24-005110:0
25,000 shares@ US$44.4010.8% of flowCommon shares without par valueSEC:0001415889-24-002080:0
25,000 shares@ US$112.507.5% of flowCommon shares without par valueSEC:0001415889-24-002080:1
17,500 shares@ US$59.942.8% of flowCommon shares without par valueSEC:0001415889-24-002080:2
17,500 shares@ US$112.505.2% of flowCommon shares without par valueSEC:0001415889-24-002080:3
15,000 shares@ US$108.004.3% of flowCommon shares without par valueSEC:0001415889-23-016642:1
15,000 shares@ US$44.406.5% of flowCommon shares without par valueSEC:0001415889-23-016642:0
4,741 shares@ US$105.001.3% of flowCommon shares without par valueSEC:0001415889-23-012074:1
244 shares@ US$105.430.1% of flowCommon shares without par valueSEC:0001415889-23-012074:2
15 shares@ US$107.420.0% of flowCommon shares without par valueSEC:0001415889-23-012074:3
5,112 shares@ US$105.001.4% of flowCommon shares without par valueSEC:0001415889-23-012074:4
272 shares@ US$105.430.1% of flowCommon shares without par valueSEC:0001415889-23-012074:5
16 shares@ US$107.420.0% of flowCommon shares without par valueSEC:0001415889-23-012074:6
5,000 shares@ US$38.401.9% of flowCommon shares without par valueSEC:0001415889-23-012074:0
25 of 70 declarations
